HopeStage
Back to all studies
TerminatedNCT00701753

A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses

Observational studyAges 19–65Canada
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 19 years to 65 years. Other eligibility criteria apply.

Listed locations
VancouverSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateMay 2008
Recruitment status
Terminated
Enrollment listed in the registry
24
Sponsor
TheraGenetics Limited
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
Interview / survey / observational
Locations
Canada
Age range
From 19 Years to 65 Years
Official registry ID
NCT00701753
Official title
Show the full official title

A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses

Recruitment & locations

Terminated

Vancouver

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is TheraGenetics Limited.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 19 years to 65 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as terminated.

Want to explore more studies?

Explore studies